AU2715700A - Methods for treating cancer and for mediating chemotaxis of dendritic cells - Google Patents
Methods for treating cancer and for mediating chemotaxis of dendritic cellsInfo
- Publication number
- AU2715700A AU2715700A AU27157/00A AU2715700A AU2715700A AU 2715700 A AU2715700 A AU 2715700A AU 27157/00 A AU27157/00 A AU 27157/00A AU 2715700 A AU2715700 A AU 2715700A AU 2715700 A AU2715700 A AU 2715700A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- dendritic cells
- treating cancer
- chemotaxis
- mediating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11449898P | 1998-12-31 | 1998-12-31 | |
US60114498 | 1998-12-31 | ||
PCT/US1999/031096 WO2000038706A2 (en) | 1998-12-31 | 1999-12-28 | Methods for treating cancer and for mediating chemotaxis of dendritic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2715700A true AU2715700A (en) | 2000-07-31 |
Family
ID=22355590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27157/00A Abandoned AU2715700A (en) | 1998-12-31 | 1999-12-28 | Methods for treating cancer and for mediating chemotaxis of dendritic cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1140141A2 (en) |
JP (1) | JP2002533402A (en) |
AU (1) | AU2715700A (en) |
WO (1) | WO2000038706A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005509B1 (en) | 1995-02-17 | 2006-02-28 | Incyte Corporation | Chemokine PANEC-1 polynucleotides and compositions and methods related thereto |
WO2001040311A1 (en) * | 1999-11-30 | 2001-06-07 | Shionogi & Co., Ltd. | Chemokine slc-il2 fused protein and gene thereof |
US7700359B2 (en) | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
US20020168358A1 (en) * | 2001-04-30 | 2002-11-14 | Gladue Ronald P. | Treatment of T-cell mediated diseases |
EP1256354A1 (en) * | 2001-05-11 | 2002-11-13 | Schering Corporation | Methods for treating cancer |
AU2003235791A1 (en) | 2002-01-08 | 2003-07-24 | Chiron Corporation | Gene products differentially expressed in cancerous breast cells and their methods of use |
CA2500661A1 (en) | 2002-10-01 | 2004-04-15 | Chiron Corporation | Anti-cancer and anti-infectious disease compositions and methods for using same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE290080T1 (en) * | 1994-08-23 | 2005-03-15 | Human Genome Sciences Inc | HUMAN BETA-9 CHEMOKINE |
WO1998014581A1 (en) * | 1996-10-02 | 1998-04-09 | Schering Corporation | Mammalian chemokines |
WO1998031809A1 (en) * | 1997-01-20 | 1998-07-23 | Shionogi & Co., Ltd. | Human cc chemokine slc |
WO2000009151A1 (en) * | 1998-08-17 | 2000-02-24 | Schering Corporation | Regulation of dendritic cell trafficking |
-
1999
- 1999-12-28 WO PCT/US1999/031096 patent/WO2000038706A2/en not_active Application Discontinuation
- 1999-12-28 AU AU27157/00A patent/AU2715700A/en not_active Abandoned
- 1999-12-28 EP EP99968968A patent/EP1140141A2/en not_active Ceased
- 1999-12-28 JP JP2000590657A patent/JP2002533402A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000038706A2 (en) | 2000-07-06 |
EP1140141A2 (en) | 2001-10-10 |
WO2000038706A3 (en) | 2000-11-23 |
WO2000038706A9 (en) | 2002-08-22 |
JP2002533402A (en) | 2002-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4655296A (en) | Compositions and methods for treating tumor cells | |
AU1939200A (en) | Electrochemical treatment of malignant tumors | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU4086899A (en) | Multi-lumen spinal implant guide and method | |
AU5788396A (en) | Methods of inhibition or killing of cancer cells | |
EP1176964B8 (en) | Uses of et743 for treating cancer | |
AU3784999A (en) | Methods for treatment of pain | |
AU2786100A (en) | Method of selecting transformed cells and tissues | |
AU6260999A (en) | Methods of treating chronic pain | |
IL124650A0 (en) | Methods and therapeutic compositions for treating cancer | |
AU2715700A (en) | Methods for treating cancer and for mediating chemotaxis of dendritic cells | |
AU8068198A (en) | Methods for treating human cancers | |
AU5241499A (en) | Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene | |
HUP0104568A3 (en) | Human prostatic cell lines for cancer treatment | |
AU4859399A (en) | Compositions and methods for treating papillomavirus-infected cells | |
AU2506499A (en) | Cea/nca-based differentiation cancer therapy | |
AU2342299A (en) | Compositions and methods for detecting and treating breast cancer | |
AU5369498A (en) | Compounds and methods for treating cancer | |
AU2487500A (en) | Dual hapten modified tumor cells and tumor polypeptides and methods of treating cancer | |
AU5097099A (en) | Methods and compositions for cancer treatment | |
GB9819999D0 (en) | Treatment of cancer | |
AU8492598A (en) | Methods and compositions for tumor reduction | |
AU2619199A (en) | Treatment of waxes | |
AU1471300A (en) | Compositions and methods for treatment of cancer | |
AU5778399A (en) | Gene therapy for treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |